FierceBiotech 2026-01-29 Roche diagnostics business nudges up 2% in '25 as China headwinds buffet Asia-Pacific sales
Roche Media 2026-01-29 Roche GLP-1 produces “robust” weight loss in late-stage obesity trial - European Pharmaceutical Review
Roche Media 2026-01-29 Roche drops $100M Kiniksa fibrosis drug from phase 2 pipeline as part of quarterly clearout - Fierce Biotech
Roche Media 2026-01-27 Roche Reports Positive Phase II Study Results for Dual GLP-1/GIP Receptor Agonist | PharmExec - Pharmaceutical Executive
Roche Media 2026-01-27 How Roche is Scaling Production After Obesity Breakthrough - Manufacturing Digital Magazine
Roche Media 2026-01-27 Roche sees GLP1/GIP drug from Carmot produce 22.5% weight loss, readies phase 3 trial - Fierce Biotech
Roche Media 2026-01-27 Roche announces positive phase II results for experimental obesity drug - wkzo.com
Roche Media 2026-01-26 Roche's Gazyva gets Health Canada approval for lupus nephritis - marketscreener.com
Roche Media 2026-01-09 Former Roche oncology head turns to Tubulis—Chutes & Ladders - fiercebiotech.com
Roche Media 2026-01-09 Roche returns to Chinese biotech MediLink for another ADC pact - Endpoints News
FierceBiotech 2026-01-09 Roche returns to MediLink with promise of $570M near-term payments for another ADC
Roche Media 2026-01-09 Roche returns to MediLink with $570M near-term payments for ADC - Fierce Biotech